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The PIK-related kinases intercept conventional signaling 
pathways 
Finny G Kuruvilla and Stuart L Schreiber 
Early efforts to place the first cloned mammalian 
PIK-related kinase, FRAP, into a conventional membrane 
to nuclear pathway met with little success. More recent 
data suggest that members of the family of PIK-related 
kinases act as intracellular sensors that govern radial 
and horizontal pathways. These pathways can impinge 
upon classical membrane to nuclear pathways, as well as 
components of the cell-cycle machinery. 
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The fascinating story behind the discovery of the phospha- 
tidylinositol kinase (PIK)-related kinases sheds much light 
on the function of these enzymes. At an early stage, it 
became clear that loss of one of these kinases would have 
many biological or medical effects that sometimes appeared 
to be unrelated. Because of their apparent involvement in 
many different processes, these kinases were not easily 
linked together. 
In 1926 a report came from Prague of three ill adoles- 
cent siblings who displayed a peculiar involuntary writhing 
movement [ 11. Their movements were so striking that serial 
photographs were included to try to capture a sense of their 
abnormal motion. Another report followed in 1941, but 
it was not until the late 1950s that Boder and Sedgwick 
[Z] codified this report with their own findings and 
described what they called ataxia-telangiectasia (AT) for 
two other striking defects that these patients bore: the 
inability to walk (ataxia), and dilated blood vessels (telang- 
iectasia) often found on the eyes or extremities. They noted 
highly pleiotropic and multisystem defects in those afflicted 
with the disease. Sinopulmonary infections were the most 
common cause of death, and lymphoreticular malignancies 
followed second. The challenge from the beginning for 
those studying AT was how to link such pleiotropic defects 
into a unifying yet reasonable mechanistic proposition. 
In a seemingly unrelated field, a team of scientists pub- 
lished a report in 1975 of a novel natural product derived 
from the microorganism Streptomyres hygroxupicus that they 
isolated on Easter Island in the South Pacific [3,4]. The 
compound potently inhibited the growth of the fungus 
Candida a&cans, faring comparably to other antifungal 
agents such as amphotericin or nystatin, but it had no 
effects on bacteria. Because the natives referred to their 
island as Rapa Nui, the natural product was named 
rapamycin. Two years later rapamycin was found to have 
extremely potent immunosuppressive activity, which 
sparked considerable medical research. Because rapamycin 
was also found to be a stereochemicdily complex macrolide 
and polyketide (Figure l), it attracted the attention of syn- 
thetic organic chemists, as did other immunosuppressive 
agents such as FK506 [S]. Why a molecule like rapamycin 
would have antifungal as well as immunosuppressive prop- 
erties remained a mystery. 
In the mid 199Os, a gene that when mutated led to rapa- 
mycin resistance in Saccharomyces cmmisiae was cloned and 
termed TORZ/DRRZ (target of rapamycin/dominant rapa- 
mycin-resistant) [6,7]. The sequence was found to code 
for a very large protein (greater than 250 kDa) that bore 
strong homology to the lipid kinase phosphatidylinositol- 
3-kinase (PI3K) in the region of its carboxyl terminus. In 
mammalian cells, the functionally relevant protein that 
binds the complex of rapamycin and its immunophilin 
receptor FKBP12 was discovered and its cDNA was cloned. 
This protein was named FRAP/RAFT (FKBP-rapamycin 
associated protein/rapamycin and FKBP target) [8,9]. It was 
found to be very similar to the protein inferred by the TORZ 
gene, including the region of homology to PI3K. The next 
year, through a large positional cloning effort, the human 
gene defective in AT was cloned and termed ATM (ataxia- 
telangiectasia mutated) [lo]. It astonishingly also coded for 
a very large protein with homology to PI3K at its carboxyl 
terminus. ATM, FRAP and TorZp all share an extreme 
carboxy-terminal tail that is also highly conserved. In 
yeast, the cDNA of another target of rapamycin, Torlp, was 
cloned and found to have the same sequence similarities 
[ll]. These four genes were therefore dubbed members of 
the PIK-related kinase family [ 121. 
Studies of mammalian, yeast and fly systems revealed six 
other PIK-related kinases. All possessed the characteristic 
PI3K-homologous kinase domain as well as the highly 
conserved carboxy-terminal tail, although none has yet 
been demonstrated to have lipid kinase activity. A high- 
molecular-weight kinase present in cell extracts found to 
be stimulated in vjtro by double-stranded DNA was dis- 
covered and termed DNA-PK (DNA-dependent protein 
kinase) [13]. Studies in Drosophila melanoga~ter uncovered 
an ATM homolog named MEI- [14]. In S. pornbe, loss of 
the PIK-related kinase RAD3 was discovered to cause 
severe radiosensitivity [lS]. Similarly in S. cerevisiae, two 
groups independently identified a PIK-related kinase 
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The chemical structures of the natural products 
rapamycin and wortmannin. Rapamycin binds 
to FKBP12 and the resulting complex inhibits 
the protein kinase FRAP. Wortmannin inhibits 
the lipid kinase Pl3K. 
called Meclp (mitosis entry checkpoint) that controls a 
checkpoint into mitosis, as well as sensitivity to DNA- 
damaging agents [ 16,171. Also in S. cemvisiae, a PIK-related 
kinase named Tellp was discovered and shown to be 
important for maintaining telomere length [18,19]. By 
homology to other PIK-related kinases, a human cDNA 
was cloned that was first named FRP (FRAP-related 
protein) but, following functional analysis, later termed 
ATR (ATM- and RAD3-related) [ lS,ZO]. 
The final and most perplexing addition to the family is the 
protein TRRAP (transformation/transcription domain asso- 
ciated protein), which was discovered by its ability to bind 
to the transcription factors c-myc and EZF [Zl]. The most 
surprising feature of TRRAP is that, although its sequence 
clearly resembles that of a PIK-related kinase, it is missing 
critical residues in the kinase domain, almost certainly 
rendering the protein devoid of kinase activity. The same 
protein was found to be present in histone acetyltrans- 
ferase/transcription regulation complexes in mammalian 
cells [Z?] and also in yeast, in which the homologous 
protein is called Tralp [23,24]. 
Altogether 12 proteins from completely different origins 
were surprisingly linked by their primary sequence homo- 
logy. Recent investigations have illuminated their func- 
tions and revealed similarities in their mechanisms of 
action. Perhaps the best understood of all the PIK-related 
kinases are mammalian FRAP and its yeast homologs 
Torlp/Zp - by understanding these proteins we may gain 
insight into all the family members. 
Rapamycin-sensitive signaling 
A potential explanation for rapamycin’s immunosuppres- 
sive effects comes from the observation that rapamycin 
potently inhibits the proliferation of immune cells such as 
T lymphocytes grown in cell culture. Rapamycin actually 
inhibits the growth of a variety of cells in different organ- 
isms such as mammalian fibroblasts or unicellular baker’s 
yeast, causing a Gl cell-cycle arrest. Rapamycin inhibits 
serum’s ability to promote the Gl to S transition in certain 
mammalian cells, therefore also leading to Gl arrest. As 
serum stimulates transmembrane receptors. initial studies 
tried to place FRAP downstream of a mitogenic receptor. 
These FRAP studies were facilitated by investigations of 
another protein, p7Ghk, a kinase important in translational 
regulation [ZS]. -p70”“k 1s multiply phosphorylated in a 
complex manner following treatment with serum; this 
phosphorylation serves to activate its inherent kinase activ- 
ity. Rapamycin potently inhibits serum-stimulated ~70~“~ 
phosphorylation, as does another natural product, wortman- 
nin, an inhibitor of the lipid kinase PI3K (Figure 1). PI3K 
binds to and is directly activated by transmembrane recep- 
tors. The finding that p70 Sbk phosphorylation is sensitive 
to wortmannin and rapamycin led to early models in which 
a transmembrane receptor activates PISK, which signals 
through FRAP to ~70”~~ (Figure 2). 
A serious blow to the linear transmembrane receptor-PI3K- 
FRAP-p7@jk model came from the construction of a 
mutant ~70”~~ that was truncated at both its amino and car- 
boxy1 termini [26]. It was shown that this modified ~70”~~ 
responded appropriately to mitogens and was wortmannin- 
sensitive. Astonishingly, it was also shown that the doubly 
truncated p70 Shk phosphorylation was rapamvcin-insensi- 
tive. This result suggests that the modified p7isbk lacks the 
region required for rapamycin inhibition. As it still signals 
normally with respect to mitogens, being potently activated 
by serum, the region required for mitogenic activation must 
still be present, however. Thus ~70”~” is probably receiving 
two distinct signals from different effecters, one coming 
from a mitogenic receptor, the other from FRAP. Hence the 
rapamycin insensitivity suggests that the serum-sensitive 
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Figure 2 
The linear PI~K-FRAP-P~O~~~ model. In this 
pathway, Pl3K is thought to be upstream of 
FRAP and lead to its activation by producing 
3-phosphoinositides. Active FRAP then 
promotes the phosphorylation of p7Ossk. 
Extracellular mitogen 
p70 S6 kinase 
signaling pathway proceeds to p70Sbk without passing 
through FRAP It is therefore unlikely that FRAP has a role 
in a linear membrane to ~70”~~ pathwav 
Although FRAP is probably not along such a linear pathway, 
rapamycin rapidly causes ~70”~~ dephosphorylation, an 
observation that must be explained. A possible model is 
that rapamycin treatment activates a phosphatase that in 
turn dephosphorylates p70 Shk. This is consistent with the 
finding that the protein phosphatase pp2A forms a complex 
with p70Sbk [27]. The idea of a phosphatase being down- 
stream of FRAP is supported by reports of a rapamycin- 
sensitive association between a phosphatase and a regula- 
tory subunit in yeast [ZS], although these results do not 
consistently hold in mammalian systems [29-311. It is also 
supported by the observation that cell extracts from rapa- 
mycin-treated cells have increased phosphatase activity 
[32]. Further evidence comes from the observation that, 
although pp2A stably binds to full-length p7DThk, it does not 
associate with the doubly truncated mutant p7Clsfik, poten- 
tially explaining its rapamycin resistance [32]. 
Rapamycin treatment elicits several other important effects 
besides the dephosphorylation and inhibition of p70Shk. 
Rapamycin also causes the dephosphorylation of the trans- 
lational factor 4EBPl [33]. It might be that the same phos- 
phatase that acts upon p70 S6k also dephosphorylates 4EBPl. 
In yeast, the serine/threonine kinase NPRl is also dephos- 
phorylated rapidly following treatment with rapamycin 
[34]. It has been proposed that NPRl control in yeast is 
analogous to the control of ~70”~~/4EBPl in mammalian 
cells. The protein p27”‘P, which potently arrests the cell 
cycle by inhibiting cyclin-dependent kinases, was also 
shown to be under the control of FRAP [35]. Rapamycin 
inhibits ~27~‘n’s downregulation caused by serum in a dis- 
tinct pathway from that involving p70shk [36]. In yeast, 
rapamycin has been reported to cause the degradation of 
the translational factor eIF4G [37]. Rapamycin has dra- 
matic translational effects in yeast, decreasing translation 
to 10% of normal levels [38], and also has a variety of 
effects on transcription [39]. Thus FRAP and Torlp/Zp 
control aspects of several diverse cellular functions, includ- 
ing post-translational modification, protein stability, trans- 
lation and transcription. 
Rapamycin’s effects on so many biological processes might 
be explained by a late cell-cycle effect. One could argue 
that cells respond to rapamycin treatment by arresting the 
cell cycle and then secondarily modulating the pathways 
described above. The kinetics of rapamycin-induced effects 
point to FRAP and,Torlp/Zp having more direct roles in 
these signaling pathways, however. Translational and tran- 
scriptional inhibition, along with eIF-4G degradation, occur 
in the time scale of,an hour, whereas ~70”“~ dephospho- 
rylation occurs wrth a t,,* of 2 minutes [40]. In yeast, NPRl 
is completely dephosphorylated on rapamycin treatment 
within 5 minutes. These kinetics indicate that FRAP and 
Torl/Zp are closely positioned to these processes. 
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Figure 3 
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A current model of FRAP function. Results 
have suggested that FRAP sits outside the 
p@sk pathway, downstream of amino acids, 
and regulates p70ssk by intercepting the Pl3K 
pathway. This model thus conveys the idea of 
PIK-related kinase horizontal signal 
transduction. 
Cell-cycle control 
Translational effects 
Horizontal signal transduction 
Like a transmembrane receptor, FRAP activates multiple 
and distinct signaling cascades in a kinetically rapid 
fashion. But instead of controlling its own pathways 
uniquely, FRAP controls pathways that transmembrane 
receptors activate. For example, FRAP regulates ~70”~~, 
even though it is under the control of mitogenic receptors. 
The situation is similar for translation in which FRAP and 
Torlp/Zp dominantly regulate key components of the 
translational machinery. In both cases, FRAP is controlling 
effecters that impinge upon core cellular processes or com- 
ponents of linear membrane to nuclear pathways (Figure 3). 
also been demonstrated to be upstream of ~53 [4S]. By 
regulating ~53, which itself controls many processes, ATM, 
ATR and DNA-PK therefore gain influence over many 
aspects of cell signaling. 
Ordinarily one thinks of signal transduction as occurring 
‘vertically’, from membrane to nucleus. This view of FRAP 
signaling, in which FRAP intercepts the more conventional 
pathways or cell-cycle proteins, resembles what might be 
called ‘horizontal’ signal transduction in two dimensions 
or ‘radial’ in three. 
Like FRAP, other PIK-related kinases have multiple and 
distinct downstream pathways. In addition to its role in 
regulating ~53, AThl has been shown to play an important 
role in the control of the nonreceptor tyrosine kinase Abl 
[4h]. Abl function is poorly understood although it was ini- 
tially characterized as a viral oncogene, implicating the 
kinase in cell-cycle function [47]. In S. pornhe, the PIK- 
related kinase RAD3 is upstream of the protein kinase 
Chkl [48]. When activated, Chkl can inhibit cd&S, which 
prevents cdcZ5 from dephosphorylating cd&?, thus causing 
cell-cycle arrest [49]. Such an intervention is an excellent 
example of a PIK-related kinase dominantly impinging on 
the cell-cycle machinery, as cdcZ is the cyclin-dependent 
kinase responsible for mitotic entry. 
Although less is known about other PIK-related kinases, a An emerging theme to PIK-related-kinase transduction is 
similar picture emerges with other family members. There the involvement of phosphatases. As discussed earlier, a 
is evidence that ATM directly phosphorylates the transcrip- phosphatase is likely to be downstream of FRAP/Torl/Zp 
tion factor p.53 in response to ionizing radiation [41,42]. ~53, in the control of P~O”~~/~EBP~/NPR~. The importance of 
widely known as the most commonly mutated gene in a phosphatase is demonstrated in yeast, in which a muta- 
cancer, can have many effects, including the induction of tion in the phosphatase regulatory subunit TAP42 confers 
cell-cycle arrest or apoptosis [43]. ATR has also been shown rapamycin resistance [28]. Another family member, ATM, 
to play an essential role in the phosphorylation and activa- also appears to be linked to a downstream phosphatase. pS3 
tion of ~53 in response to both ionizing radiation and ultra- undergoes an ATM-dependent dephosphorylation step after 
violet light [44]. A third PIK-related kinase, DNA-PK, has ionizing radiation, which in turn leads to 14-3-3 protein 
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binding to the resulting monophosphorylated protein [SO]. 
14-3-3 proteins, which bind certain elements in proteins 
containing phosphoserine and phosphothreonine residues, 
have been genetically linked to the Torlp/Zp signaling 
pathway in yeast, suggesting common features in the 
Torlp/Zp and ATM mechanisms [Sl]. 
Indirect support for FRAP and Torlp/Zp themselves 
binding to a phosphatase comes from the identification of 
a protein motif known as the HEAT repeat [SZ]. The 
HEAT repeat occurs 15 times in tandem and comprises 
the entire sequence of the A subunit of the phosphatase 
pp2A. The A subunit directly binds to the catalytic, or C, 
subunit of the phosphatase. The structure of the A sub- 
unit of pp2A has been determined to consist of elongated 
and repeating pairs of antiparallel ~1 helices [53]. The 
HEAT repeat occurs approximately 20 times in TORlp/Zp 
and FRAP. Given the sequence homology, FRAP and 
Torlp/Zp might bind directly to the catalytic subunit of 
pp2A through their own HEAT repeats. Indeed, although 
it has not yet been established in ho, it has been demon- 
strated that FRAP can directly phosphorylate the cat- 
alytic subunit of ppZA Zn vitro 1321. 
What are the regulators of the PIK-related kinases? If 
FRAP is not under the control of mitogenic receptors, then 
what is the signal that modulates its activity? And what 
might be regulating ATM, ATR and DNA-PK functions? 
Regulating the PIK-related kinases 
Recent studies of ~70 Shk have shed light on FRAP regula- 
tion. It was discovered that amino acids have even more 
potent control over ~70 S6k than does serum. Amino-acid 
withdrawal results in the rapid clephosphorylation of p70shk, 
and without amino acids in the media, serum stimulation 
of p70s”k is ineffective [54,551. One of the most intrigu- 
ing observations about amino-acid withdrawal is that the 
doubly truncated p70Sbk IS resistant to the dephosphoryla- 
tion induced by amino-acid withdrawal, as it is with rapa- 
mycin [SS]. Although this is only correlative evidence 
implicating FRAP, it is highly suggestive that FRAP might 
be sensing amino acids. 
The notion of FRAP as an amino-acid sensor is supported 
by other reports in the literature. It has been noted that rapa- 
mycin treatment causes yeast to enter a state that resembles 
the starvation response [38]. Indeed, tor2 kinase-dead over- 
expression also causes yeast to appear starved, both with 
regard to morphology and gene expression. More recent data 
also indicate that Torlp/Zp control autophagocytosis, the 
process by which the cell’s own organelles and free proteins 
are digested and recycled, thus providing an internal source 
of amino acids and other metabolites [56]. Torlp/Zp were 
demonstrated to be genetically upstream of every member 
of a panel of autophagic mutants, suggesting an upstream 
position in the control of autophagy. It is interesting to note 
that autophagocytosis is potently inhibited by amino acids. 
Rapamycin’s induction of autophagocytosis occurs even if 
cells are arrested, irrespective of which phase of the cell 
cycle the arrest occurs, again implying a cell-cycle-indepen- 
dent and direct connection into the pathway. Together 
these additional observations support FRAP and TORlp/Zp 
having an early role in amino-acid sensing. 
A possible mechanism by which FRAP senses amino-acid 
levels is to detect the abundance of charged tRNA. When 
amino acids are scarce, uncharged tRNA levels rise and 
charged tRNA levels fall. It is possible that FRAP senses 
these changes, thereby indirectly detecting amino-acid 
levels. This model is supported by the demonstration that 
inhibitors of tRNA charging lead to the dephosphorylation 
of p70Shk, even in the presence of amino acids [57]. 
Regarding ataxia-telangiectasia, ATM knockout mice reca- 
pitulate the human disorder and are afflicted by lym- 
phomas, radiosensitivity, immune defects, sterility and 
growth abnormalities [58,59]. One of the most striking 
defects in ATM knockout mice is their exquisite sensitiv- 
ity to ionizing radiation. As mentioned earlier, ATM-‘- 
cells are also defective in their ~53 response to ionizing 
radiation. With the PIK-related kinase ATR, overexpres- 
sion of a kinase-dead allele of ATR causes similar sensi- 
tivity to ionizing radiation to that found in AThI-I- cells, 
along with sensitivity to genotoxic agents such as cis- 
platinum or methyl methanesulfonate [60]. These results 
strongly suggest that ATM and ATR are both involved in 
sensing DNA damage. 
Roles for ATM and ATR in meiosis were suggested on the 
basis of immunofluorescence studies that identified both 
proteins on meiotic chromosomes [61]. Their localization 
suggests they have a role in responding to the normal 
strand breaks that occur in meiosis as chromosomes break 
and join with their homologous partner. Given the meiotic 
defects of the ATM knockout mouse as well as the impair- 
ment of meiosis in mec2 mutant yeast, it is apparent that 
ATM and other PIK-related kinases are playing a funda- 
mental role in meiosis. As ATM plays a role in processing 
the normal strand breaks that occur in meiosis, it is proba- 
bly playing a similar role with the non-natural strand 
breaks that occur with ionizing radiation. 
Such a precedent is mimicked with DNA-PK. It was found 
that mice defective in DNA-PK are immunodeficient and 
sensitive to the DNA damage caused by X rays [62,63]. 
Cells deficient in functional DNA-PK are also defective in 
V(D)J recombination, the process by which antibody genes 
are cut and joined, thus rearranging their coding sequences 
in order to generate diversity. Like ATM and ATR, DNA- 
PK probably processes the normal DNA breaks of V(D)J 
recombination as well as the non-natural double-stranded 
breaks caused by X rays. Both would require cell-cycle arrest 
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A possible model for PIK-related kinase 
sensing. In this model, the common feature of 
PIK-related kinase sensing is their detection of 
nucleic-acid modifications. FRAP and 
Torl p/2p would detect the increased tRNA 
deacylation that occurs when amino acids are 
scarce whereas ATM, ATR, and DNA-PK 
would detect DNA damage after genotoxic 
stress. 
and repair until the break was corrected. In this way, the loss 
of DNA-PK causing immunodeficiency as well as sensitivity 
to radiation-induced strand breaks might be explained. 
Prospects 
Using electron crystallography, a structure of DNA-PK with 
22 w resolution was obtained [64]. Its structure is highly 
sculpted and contains multiple channels and grooves where 
single- and double-stranded DNA may bind. Using both 
structural and biochemical data an elegant molecular mech- 
anism has been proposed that explains how the kinase 
activity of DNA-PK might be modulated by the presence of 
double-stranded breaks [64]. 
As ATM, ATR and DNA-PK all respond to DNA damage, 
whereas FRAP and Torlp/2p possibly detect tRNA charg- 
ing status, it is tempting to suggest that perhaps the PIK- 
related kinases are unified through a role of sensing nucleic 
acids, whether it be DNA or RNA (Figure 4). Such a model 
does not exclude the possibility of other proteins being 
involved in the sensing mechanism, as has already been 
demonstrated with the Ku proteins and DNA-PK [65]. 
The last five years have witnessed many leaps in our 
understanding of the PIK-related kinases. We are begin- 
ning to understand how deeply embedded they are in 
such processes as the control of transcription, translation, 
growth, the cytoskeleton, as well as the response to DNA 
damage and starvation. But despite our advances, the 
mechanisms of their actions remain mysterious. The 
mystery of the homology to lipid kinases is unclear, espe- 
cially as no lipid substrates have been found. Although the 
discovery of protein substrates like ~53 is exciting, the 
existence of family members like TRRAP/Tralp that 
appear to be devoid of kinase activity suggests that there 
may be more to downstream function than simple phos- 
phorylation. There is no known function of the highly 
conserved tail possessed by all family members and the 
reason for their extraordinarily large size is also not under- 
stood. With the exception of the FKBP-rapamycin binding 
(FRB) domain of FRAP [70], there is no atomic-level 
structural information for any of the domains of these pro- 
teins, most notably lacking in the kinase and tail regions. 
These kinases also have functions not modulated by their Although members of this family of proteins act as sensors 
canonical sensor activity. In some cases, these additional of factors critical to the cell, how they are able to sense 
functions are essential. In yeast, TORZ deletion is lethal, these factors is unknown. It will no doubt be fascinating to 
attributable to a cytoskeletal defect in actin organization understand in rigorous molecular detail how these kinases 
[66]. This function of TorZp is amino-acid- and rapamycin- behave as sensors, whether it be in DNA-damage detec- 
insensitive, consistent with its kinase domain being dif- tion, meiotic strand-break sensing, or nutrient-status mon- 
ferentially regulated [67]. In ATM-‘- cells, serum is ineffi- itoring. Surveillance of genomic integrity alone is one of 
cient in promoting the Gl to S transition [68]. ATM-I- cells the most important tasks a cell has, and the PIK-related 
also senesce prematurely, dying only after a few passages in kinases are central to this process. They may even be 
culture. ATM therefore performs additional functions that more accurately termed the ‘guardians of the genome’, a 
are not responses to sensing DNA damage. Similarly, Mecl p term famously applied to p.53, because the PIK-related 
in yeast has an essential function which is related to the kinases operate in unicellular organisms that lack ~53. In 
maintenance of the free deoxynucleotide pool [69]. mammalian cells, ~53 is downstream of three PIK-related 
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kinases - ATM, ATR and DNA-PK. Indeed ~53 may be 
simply the PIK-related kinase effector into some of path- 
ways that the family controls in mammalian cells. 
So far, the PIK-related kinases have been recalcitrant to 
placement in traditional pathways. It will be important to 
understand the nature of the signals propagating from 
these intracellular receptors in order to understand the 
family’s relationship to conventional cell signaling. How 
does the program of cell-cycle arrest, entering starvation or 
invoking DNA repair actually occur? There are at present 
no satisfying answers to these questions. 
Given the highly conserved nature of the PIK-related 
kinases in plants, fungi, nematodes and mammals, it is 
clear that they play central roles in many diverse species. 
Understanding these mysterious kinases will provide 
insights into immunology, the cytoskeleton, nutrient 
sensing, apoptosis and cancer that will undoubtedly lead 
to important advances in medicine and in understanding 
eukaryotic life itself. 
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